XML 109 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
EQUITY - Schedule of Stock Options, SARS, and Non-vested Restricted Stock (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Non-vested Restricted Stock      
Outstanding, beginning of year (in shares) 100,025 103,891 83,956
Granted (in shares) 59,745 38,668 53,358
Canceled (in shares) (62) (2,711) (1,184)
Vested and issued (in shares) (45,355) (39,823) (32,239)
Outstanding, end of year (in shares) 114,353 100,025 103,891
Weighted- Average Grant Date Fair Value      
Outstanding, beginning of year (in dollars per share) $ 91.84 $ 78.55 $ 71.76
Granted (in dollars per share) 135.56 120.14 88.92
Canceled (in dollars per share) 88.68 97.44 79.82
Vested and issued (in dollars per share) 78.12 84.25 77.98
Outstanding, end of year (in dollars per share) $ 120.13 $ 91.84 $ 78.55
SARs      
Stock Options and SARs      
Outstanding, beginning of year (in shares) 132,163 130,409 116,417
Granted (in shares) 16,761 18,432 28,575
Exercised (in shares) (22,972) (16,678) (14,583)
Canceled (in shares) 0 0 0
Outstanding, end of year (in shares) 125,952 132,163 130,409
Exercisable at end of year (in shares) 87,378 83,054 72,106
Weighted- Average Exercise Price      
Outstanding, beginning of year (in dollars per share) $ 75.82 $ 66.10 $ 57.16
Granted (in dollars per share) 135.12 120.38 88.68
Exercised (in dollars per share) 56.82 49.04 38.99
Canceled (in dollars per share) 0 0 0
Outstanding, end of year (in dollars per share) 87.18 75.82 66.10
Exercisable at end of year (in dollars per share) $ 73.15 $ 63.12 $ 52.85